The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma

Journal of Psychosomatic Research

Volumn 66, Issue 3, 2009, Pages 259-266

  Wei, Yong chang ^a   Zhou, Fu ling ^a   He, Da lin ^a   Bai, Ji rong ^a   Hui, Ling yun ^a   Wang, Xin yang ^a   Nan, Ke jun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

8 hydroxy deoxyguanosine; Colorectal carcinoma; Depression; DNA damage; Gene expression; HAMD; HRAD51; Oxidative stress; p34

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; DEPRESSIVE DISORDER; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PERSONALITY INVENTORY; PSYCHOMETRICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 59849113945     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2008.09.001     Document Type: Article

References (43)

1. Lunec J., Halligan E., Mistry N., and Karakoula K. Effect of vitamin E on gene expression changes in diet-related carcinogenesis. Ann N Y Acad Sci 1031 (2004) 169-183
2. Hold G.L., and El-Omar M.E. Genetic aspects of inflammation and cancer. Biochem J 410 (2008) 225-235
3. Skrzydlewska E., Sulkowski S., Koda M., Zalewski B., Kanczuga-Koda L., and Sulkowska M. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 11 (2005) 403-406
4. Somogyi A., Rosta K., Pusztai P., Tulassay Z., and Nagy G. Antioxidant measurements. Physiol Meas 28 (2007) R41-R55
5. Rainis T., Maor I., Lanir A., Shnizer S., and Lavy A. Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Dig Dis Sci 52 (2007) 526-530
6. Hwang E.S., and Kim G.H. Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 229 (2007) 1-10
7. Miyake H., Hara I., Kamidono S., and Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol 171 (2004) 1533-1536
8. Wang X., Cheung H.W., Chun A.C., Jin D.Y., and Wong Y.C. Mitotic checkpoint defects in human cancers and their implications to chemotherapy. Front Biosci 13 (2008) 2103-2114
9. Tsunoda A., Nakao K., Hiratsuka K., Yasuda N., Shibusawa M., and Kusano M. Anxiety, depression and quality of life in colorectal cancer patients. Int J Clin Oncol 10 (2005) 411-417
10. Jeon H.J., Shim E.J., Shin Y.W., Oh D.Y., Im S.A., Heo D.S., and Hahm B.J. Discrepancies in performance status scores as determined by cancer patients and oncologists: are they influenced by depression?. Gen Hosp Psychiatry 29 (2007) 555-561
11. Pai A.L., Drotar D., Zebracki K., Moore M., and Youngstrom E. A meta-analysis of the effects of psychological interventions in pediatric oncology on outcomes of psychological distress and adjustment. J Pediatr Psychol 31 (2006) 978-988
12. Macvean M.L., White V.M., Pratt S., Grogan S., and Sanson-Fisher R. Reducing the unmet needs of patients with colorectal cancer: a feasibility study of The Pathfinder Volunteer Program. Support Care Cancer 15 (2007) 293-299
13. Halliwell B. Oxidative stress and neurodegeneration. Where are we now?. J Neurochem 97 (2006) 1634-1658
14. Ng F., Berk M., Dean O., and Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol (2008) 1-26
15. Lukash A.I., Zaika V.G., Kucherenko A.O., and Miliutina N.P. Free radical processes and antioxidant system in depression and treatment efficiency. Zh Nevrol Psikhiatr Im S S Korsakova 102 (2002) 41-44
16. Berk M., Ng F., Dean O., Dodd S., and Bush A.I. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci 29 (2008) 346-351
17. Grinberg L., Fibach E., Amer J., and Atlas D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic Biol Med 38 (2005) 136-145
18. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., McDonald W.M., Avery D., Fitzgerald P.B., Loo C., Demitrack M.A., George M.S., and Sackeim H.A. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 62 (2007) 1208-1216
19. Dugan W., McDonald M.V., Passik S.D., Rosenfeld B.D., Theobald D., and Edgerton S. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psychooncology 7 (1998) 483-493
20. Zung W.W. A rating instrument for anxiety disorders. Psychosomatics 12 (1971) 371-379
21. Efficace F., Bottomley A., Vanvoorden V., and Blazeby J.M. Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. Eur J Cancer 40 (2004) 187-197
22. Zhou F.L., Zhang W.G., Wei Y.C., Xu K.L., Hui L.Y., Wang X.S., and Li M.Z. Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers. World J Gastroenterol 11 (2005) 2313-2318
23. Yuet L.M., Alexander M., and Chun C.J. Coping and adjustment in Chinese patients with chronic obstructive pulmonary disease. Int J Nurs Stud 39 (2002) 383-395
24. Spiegel B.M., Gralnek I.M., Bolus R., Chang L., Dulai G.S., Naliboff B., and Mayer E.A. Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?. Gastrointest Endosc 62 (2005) 892-899
25. Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai 90 (2007) 2164-2174
26. Gidron Y., Russ K., Tissarchondou H., and Warner J. The relation between psychological factors and DNA-damage: a critical review. Biol Psychol 72 (2006) 291-304
27. Cesaratto L., Vascotto C., Calligaris S., and Tell G. The importance of redox state in liver damage. Ann Hepatol 3 (2004) 86-92
28. Buldanlioglu S., Turkmen S., Ayabakan H.B., Yenice N., Vardar M., Dogan S., and Mercan E. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease. Br J Dermatol 153 (2005) 526-530
29. Ozcan M.E., Gulec M., Ozerol E., Polat R., and Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 19 (2004) 89-95
30. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., Kap O., Yumru M., Savas H.A., and Akyol O. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38 (2007) 247-252
31. Forlenza M.J., and Miller G.E. Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosom Med 68 (2006) 1-7
32. Irie M., Miyata M., and Kasai H. Depression and possible cancer risk due to oxidative DNA damage. J Psychiatr Res. 39 (2005) 553-560
33. Nussenzweig A. Causes and consequences of the DNA damage response. Cell Cycle 6 (2007) 2339-2340
34. Simonatto M., Latella L., and Puri P.L. DNA damage and cellular differentiation: more questions than responses. J Cell Physiol 213 (2007) 642-648
35. Alvarez M.J., Vila-Ortiz G.J., Salibe M.C., Podhajcer O.L., and Pitossi F.J. Model based analysis of real-time PCR data from DNA binding dye protocols. BMC Bioinformatics 8 (2007) 85
36. Wang M., Vikis H.G., Wang Y., Jia D., Wang D., Bierut L.J., Bailey-Wilson J.E., Amos C.I., Pinney S.M., Petersen G.M., de Andrade M., Yang P., Wiest J.S., Fain P.R., Schwartz A.G., Gazdar A., Minna J., Gaba C., Rothschild H., Mandal D., Kupert E., Seminara D., Liu Y., Viswanathan A., Govindan R., Anderson M.W., and You M. Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Res 67 (2007) 93-99
37. Velasco-Miguel S., Buckbinder L., Jean P., Gelbert L., Talbott R., Laidlaw J., Seizinger B., and Kley N. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18 (1999) 127-137
38. Kim H.J., Woo H.Y., Koo H.H., Tak E.Y., and Kim S.H. ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: report of the first case. Am J Hematol 76 (2004) 360-363
39. Rukść A., Birmingham E.C., and Baker M.D. Altered DNA repair and recombination responses in mouse cells expressing wildtype or mutant forms of RAD51. DNA Repair (Amst) 6 (2007) 1876-1889
40. Nowacka-Zawisza M., Bryś M., Romanowicz-Makowska H., Kulig A., and Krajewska W.M. Genetic instability in the RAD51 and BRCA1 regions in breast cancer. Cell Mol Biol Lett 12 (2007) 192-205
41. Liu Y., Tarsounas M., O'regan P., and West S.C. Role of RAD51C and XRCC3 in genetic recombination and DNA repair. J Biol Chem 282 (2007) 1973-1979
42. Loignon M., Amrein L., Dunn M., and Aloyz R. XRCC3 depletion induces spontaneous DNA breaks and p53-dependent cell death. Cell Cycle 6 (2007) 606-611
43. Zhang W., Bae I., Krishnaraju K., Azam N., Fan W., Smith K., Hoffman B., and Liebermann D.A. CR6: A third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 18 (1999) 4899-4907